Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 27, 2024
The artificial intelligence (AI) in drug discovery market is projected to reach USD 4.9 billion by 2028 from USD 900 million in 2023, at a CAGR of 40.2%
read more
Tuesday, February 19, 2019
Gliknik announced that it will receive a $15 million milestone payment from Pfizer following the start of a Phase I clinical trial of Pfizer drug candidate PF-06755347, previously known as GL-2045.
read more
Glenmark Pharmaceuticals and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302.
read more
Monday, December 23, 2019
Glenmark Pharmaceutical announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level.
read more
Glenmark Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) cleared the Company's Investigational New Drug (IND) application to begin a Phase 2 study of GSP 304 (tiotropium bromide) for administration by nebulization for ...
read more
Thursday, February 07, 2019
Perrigo has received final approval from the FDA for its AB rated Abbreviated NDA referencing Zovirax Cream, 5% (acyclovir cream, 5%) developed in collaboration with Sol-Gel Technologies.
read more
Glenmark Pharmaceuticals has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma.
read more
Glenmark Pharmaceuticals announced its subsidiary Glenmark Specialty has entered into an exclusive licensing agreement with Seqirus to commercialize Ryaltris in Australia and New Zealand.
read more
Glen Research has achieved ISO 9001:2015 certification.
read more
Arria NLG announced a collaboration with Glemser Technologies to bring scalable automation solutions and major efficiencies to healthcare and pharmaceuticals companies.
read more
GlaxoSmithKline’s Sligo plant will close the plant and lay off its 165 workers over the next three years.
read more
Delpharm, will acquire GlaxoSmithKline’s Poznan manufacturing facility in Poland.
read more
Thursday, August 31, 2017
GlaxoSmithKline has selected SciBite's Semantic Platform to enhance pharmacovigilance capabilities and deliver on its commitment to improve the quality of human life.
read more
Wednesday, August 12, 2015
GlaxoSmithKline shut down a plant Tuesday that produces inhaled medications after discovering the bacteria that causes Legionnaire's disease, a potentially fatal form of pneumonia.
read more
Wednesday, December 13, 2023
Ginkgo Bioworks has been awarded a grant by the Bill & Melinda Gates Foundation to advance a groundbreaking cell-based technology, aiming to enhance the delivery of protein therapeutics to patients in low- and middle-income countries (LMICs).
read more